XML 24 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Stockholders' Equity
Stockholders' Equity
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Capital In Excess of Par Value
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjustment
Treasury Stock
Noncontrolling Interest
Balance (in shares) at Dec. 31, 2020         127,009,536              
Balance at Dec. 31, 2020 $ 617,768   $ 617,766   $ 1,270 $ 153,800 $ 1,549,950   $ 8,198   $ (1,095,452) $ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income 306,288   305,871       305,871         417
Dividends declared (80,070)   (80,070)       (80,070)          
Currency translation adjustments 6,173   6,173           6,173      
Derivative financial instruments (198)   (198)           (198)      
Defined benefit obligations (2,120)   (2,120)           (2,120)      
Available-for-sale investments 90   90           90      
Exercises of stock options (in shares)         76,682              
Exercises of stock options 1,878   1,878     1,878            
Shares placed in treasury (230,828)   (230,828)               (230,828)  
Stock-based compensation charges (in shares)         225,767              
Stock-based compensation charges 18,613   18,613   $ 3 18,610            
Distributions to noncontrolling interests (359)                     (359)
Balance (in shares) at Dec. 31, 2021         127,311,985              
Balance at Dec. 31, 2021 637,235 $ 0 637,175 $ 0 $ 1,273 174,288 1,775,751 $ 0 12,143 $ 0 (1,326,280) 60
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income 238,620   238,191       238,191         429
Dividends declared (80,972)   (80,972)       (80,972)          
Currency translation adjustments (34,834)   (34,834)           (34,834)      
Derivative financial instruments 799   799           799      
Defined benefit obligations 67   67           67      
Available-for-sale investments (105)   (105)           (105)      
Exercises of stock options (in shares)         35,878              
Exercises of stock options 852   852     852            
Shares placed in treasury (26,990)   (26,990)               (26,990)  
Stock-based compensation charges (in shares)         323,893              
Stock-based compensation charges 14,127   14,127   $ 4 14,123            
Distributions to noncontrolling interests $ (444)                     (444)
Balance (in shares) at Dec. 31, 2022 127,671,756       127,671,756              
Balance at Dec. 31, 2022 $ 748,355 $ 0 748,310 $ 0 $ 1,277 189,263 1,932,970 $ 0 (21,930) $ 0 (1,353,270) 45
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income 246,321   245,849       245,849         472
Dividends declared (84,902)   (84,902)       (84,902)          
Currency translation adjustments 12,876   12,876           12,876      
Derivative financial instruments 453   453           453      
Defined benefit obligations 1,038   1,038           1,038      
Available-for-sale investments 100   100           100      
Exercises of stock options (in shares)         56,005              
Exercises of stock options 1,323   1,323   $ 2 1,321            
Shares placed in treasury (7,592)   (7,592)               (7,592)  
Stock-based compensation charges (in shares)         337,760              
Stock-based compensation charges 15,896   15,896   $ 2 15,894            
Distributions to noncontrolling interests $ (567)                     (567)
Balance (in shares) at Dec. 31, 2023 128,065,521       128,065,521              
Balance at Dec. 31, 2023 $ 933,301   $ 933,351   $ 1,281 $ 206,478 $ 2,093,917   $ (7,463)   $ (1,360,862) $ (50)